Marvel Biosciences Corp.: Marvel Biosciences Announces Proxy Tabulation and Shareholder Meeting Results
Calgary, Alberta--(Newsfile Corp. - February 15, 2022) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased
Source: finanznachrichten.de